Resumo

Background: Coronário ateroscleroseA aterosclerose é a doença por trás da maioria dos ataques cardíacos e de muitos acidentes vasculares cerebrais. Partículas de colesterol ficam presas na parede de uma artéria, o corpo envia células imunológicas para limpar e, ao longo dos anos, essa bagunça endurece, transformando-se em placa., long thought to be an inexorably progressive disease, is now recognized as biologically reversible under specific metabolic and inflammatory conditions. Imaging studies using ultrassom intravascularIntravascular ultrasound, or IVUS, uses a tiny ultrasound probe threaded inside a coronary artery to photograph the wall from within. (IVUS), coronary tomografia computadorizadaComputed tomography, or CT, takes X-ray images from many angles and reconstructs them into cross-sections of the body. angiography (CCTA), and angiografia coronariana quantitativaQuantitative coronary angiography is a way of measuring artery narrowing precisely from angiogram images, rather than eyeballing it. (QCA) consistently demonstrate that aggressive hipolipemianteLipid lowering means reducing the harmful, ApoB-carrying particles in your blood — through food, medication, or both. or comprehensive lifestyle change can induce measurable regression of carga de placaPlaque burden is the total amount of plaque in your arteries, everywhere — not just at the single worst spot.. However, luminal area often fails to expand in parallel—a phenomenon termed the lumen paradoxThe observation that measurable plaque regression—confirmed by reductions in atheroma volume on IVUS or CCTA—is often not accompanied by a corresponding increase in luminal diameter, because the outer arterial wall simultaneously contracts (reverse remodeling) back toward its pre-disease size.. For endurance athletes, who rely on high coronary flow reserveCoronary flow reserve compares blood flow through the heart's arteries at rest with flow when the heart is working hard. and robust endothelial responsiveness, understanding this paradox is crucial.

Content: This review synthesizes mechanistic, clinical, and physiologic data regarding regressão de placaA regressão da placa significa que a placa existente realmente diminui de tamanho, em vez de apenas crescer mais devagar. and vascular remodeling, with special attention to the athlete’s heart. It integrates pharmacologic approaches (estatinasUma estatina desacelera a enzima que seu fígado usa para produzir colesterol. Seu fígado responde puxando mais colesterol do que está no seu sangue, que é de onde vem o verdadeiro benefício., Inibidores da PCSK9Um inibidor da PCSK9 é um medicamento que bloqueia essa proteína destruidora de colesterol, deixando mais pontos de ancoragem disponíveis para remover partículas do sangue., omega-3 therapy) with evidence for whole-food, plant-based (WFPB) nutritional strategies derived from the work of Dean Ornish and colleagues. The review further examines the paradoxical coexistence of regression and remodelação restritivaA paradoxical shrinkage of the external elastic membrane that can accompany plaque regression, causing the vessel wall to contract inward rather than expand outward; the result is that lumen size stays the same or even decreases even as total plaque volume falls., explores hemodynamic consequences for high-output circulation, and highlights new findings in subclinical coronary disease among master athletes.

Summary: PlacaPlaca é o acúmulo de colesterol, células imunológicas, tecido cicatricial e cálcio dentro da parede de uma artéria. regression represents authentic arterial healing—characterized by lipid clearance, fibrous stabilization, and inflamaçãoA inflamação é a resposta do seu sistema imunológico a uma lesão ou a algo que ele trata como um invasor. Ela traz inchaço, calor e células de limpeza. resolution—even when luminal dimensions appear static. Pharmacologic therapy secures biochemical normalization, while WFPB nutrition restores função endotelialA capacidade do revestimento interno dos vasos sanguíneos de regular o tônus vascular, a inflamação e a coagulação; células endoteliais saudáveis liberam óxido nítrico para manter as artérias relaxadas e resistentes à formação de placas. and vasomotor capacity. Together they yield structural resilience and physiologic performance.

Key Messages:

1. Atherosclerosis regression is biologically real and clinically measurable.
2. O lúmenThe lumen is the open channel inside a blood vessel where blood actually flows. paradox arises from reverse remodelingThe inward movement of the external elastic membrane that occurs as plaque burden decreases, returning the artery toward its original, smaller caliber rather than enlarging the lumen; it is the principal explanation for the lumen paradox., not treatment failure.
3. Endothelial nitric-oxide–driven vasodilation may permit remodelação externaOutward remodeling (also called compensatory or positive remodeling) is the process by which an artery expands its outer diameter to accommodate growing plaque, preserving the inner lumen even as the artery wall becomes more diseased; because of this, standard tests that measure only the lumen opening can miss substantial atherosclerosis. under WFPB conditions.
4. For endurance athletes, vascular healing and flow optimization are dual therapeutic goals.

Background

Atherosclerosis begins with retenção subendotelialSubendothelial retention is the process by which ApoB-containing lipoprotein particles that have crossed the endothelial barrier become electrostatically bound to proteoglycans in the arterial intima and are unable to diffuse back into the bloodstream; it is considered the non-redundant first step in atherosclerosis under the response-to-retention framework. de apolipoproteínaUma apolipoproteina é uma proteína ligada a uma partícula transportadora de gordura no sangue. A gordura e a água não se misturam, portanto, essas proteínas agem como um invólucro que permite que a gordura viaje com segurança pela corrente sanguínea. B–containing lipoproteínasUma lipoproteína é um pequeno pacote que transporta gordura e colesterol através da sua corrente sanguínea. Como a gordura não se dissolve em água, ela precisa de um invólucro de proteína para viajar.. Oxidative modification of LDLO LDL, ou lipoproteína de baixa densidade, é a principal partícula que transporta colesterol pelo sangue — e a principal que fica presa nas paredes das artérias. particles triggers a cascade of monocyte adhesion, macrófagoUm macrófago é uma grande célula imune que engole detritos e invasores. O nome significa literalmente "comedor grande"." activation, and smooth-muscle migration. Over decades this leads to lipid-rich, inflamed, and fibrotic plaques that compromise arterial elasticity. Historically, the disease was deemed irreversible; autopsy data from the mid-twentieth century depicted monotonically progressive espessamento intimalIntimal thickening is an early adaptive or pathological increase in the thickness of the innermost layer of an artery (the intima), which can reflect either normal developmental changes or the accumulation of smooth muscle cells, lipids, and inflammatory cells that precede overt plaque formation. It is measurable non-invasively by carotid intima-media thickness ultrasound..

However, discoveries in lipid metabolism, macrophage biology, and vascular imaging overturned this fatalism. When the influx of partículas aterogênicasPartículas aterogênicas são as lipoproteínas contendo ApoB — incluindo LDL, IDL, VLDL e a lipoproteína(a) — que podem entrar e ficar retidas na parede arterial para iniciar e sustentar o crescimento da placa; o artigo usa o termo para descrever o que deve ser reduzido de forma substancial e sustentável para alcançar a regressão da placa. ceases and inflammation resolves, plaques can shrink and re-stabilize. The modern view is of a dynamic equilibrium between injury and repair—a process profoundly influenced by colesterolO colesterol é uma substância cerosa de que seu corpo precisa. Ele vai para as paredes celulares, hormônios, vitamina D e a bile que digere sua comida. Você morreria sem ele. transport, endothelial integrity, and systemic inflammation.

Regression involves three interdependent domains:

• Plaque biology – lipid depletion, macrophage phenotype switching, matriz extracelularThe extracellular matrix is the scaffolding of collagen and other fibers that holds tissue together and gives an artery wall its strength. reconstruction.
• Vessel remodeling – outward or inward movement of the external elastic membrane adjusting wall stress.
• Vasomotor toneThe degree of active contraction or relaxation of smooth muscle in the arterial wall that continuously adjusts lumen diameter in response to metabolic demand, endothelial signals such as nitric oxide, and neural input; improved vasomotor tone after lifestyle intervention can widen the functional lumen even without structural plaque loss. – endothelial nitric-oxide–dependent relaxation of vascular smooth muscle.

Em ensaios clínicosUm ensaio clínico é um estudo em que os pesquisadores dão a um grupo um tratamento e a outro grupo um placebo ou tratamento padrão, e depois comparam o que acontece., interventions often improve the first domain while leaving the latter two unchanged or even contracted, giving rise to the lumen paradox.

Mechanisms of Regression

Lipid and Cellular Dynamics

When plasma LDL-cholesterol falls below the threshold for intimal retention (≈50 mg/dL), lipid influx subsides. Macrophage células espumosasUma célula espumosa é uma célula imunológica que ingeriu tanto colesterol preso que se expande e assume uma aparência espumosa sob o microscópio. activate ATP-binding cassette transporters ABCA1A ABCA1 é uma proteína que bombeia colesterol para fora das células e o entrega às partículas de HDL para a viagem de volta ao fígado. and ABCG1, exporting cholesterol to apoA-I and HDLHDL, ou lipoproteína de alta densidade, é a partícula frequentemente chamada de "bom colesterol". Ela coleta o colesterol dos tecidos e o transporta de volta para o fígado.. As cholesterol efflux exceeds influx, intracellular lipid droplets dissolve, and macrophages adopt a reparative M2 phenotype that secretes anti-inflammatory cytokines and matrix components.

Inflammation Resolution and Matrix Remodeling

Reduced activation of NF-κB and Inflamassomo NLRP3O inflamassoma NLRP3 é um complexo proteico intracelular em células imunológicas que, quando ativado por cristais de colesterol, lipídios oxidados ou outros sinais de perigo dentro de uma placa aterosclerótica, desencadeia a liberação das citocinas inflamatórias interleucina-1β e interleucina-6, acelerando o crescimento e a instabilidade da placa. pathways decreases interleukin-1β and tumor necrosis factor α. Matrix metalloproteinaseMatrix metalloproteinases are enzymes that cut through the collagen scaffolding of tissue. Immune cells inside plaques release them. (MMP) expression declines while tissue inhibitors of metalloproteinases (TIMPs) rise, favoring fibrous-cap thickening. Collagen synthesis by smooth-muscle cells stabilizes the lesãoNa cardiologia, uma lesão refere-se a uma área delimitada de placa aterosclerótica que estreita uma artéria coronária, normalmente descrita pela porcentagem de obstrução luminal que causa. O artigo descreve quatro lesões residuais cujo diâmetro do vaso é pequeno demais para permitir a implantação de um stent após o tratamento da lesão mais crítica. and prevents rupture.

Endothelial Recovery and Nitric Oxide Biology

Endothelial nitric oxide synthase (eNOS)Endothelial nitric oxide synthase is the enzyme in artery-lining cells responsible for producing nitric oxide, which relaxes blood vessels and suppresses clot formation; in insulin resistance, impaired insulin-receptor signaling downregulates eNOS, reducing nitric oxide availability and promoting an adhesive, pro-inflammatory arterial surface. uncoupling, a hallmark of estresse oxidativoOxidative stress is an imbalance between damaging reactive molecules and the body's ability to neutralize them., is reversed as tetrahydrobiopterin availability improves. NO restores vasodilation, inhibits platelet aggregation, and reduces adesão leucocitáriaThe process by which white blood cells attach to the endothelial surface of blood vessels, a key early step in atherogenesis; nitric oxide and an intact glycocalyx normally suppress this adhesion.. Exercise, plant nitrates, and polifenóisPolyphenols are a broad class of plant-derived compounds with antioxidant properties; extra virgin olive oil is particularly rich in them, and they are often cited as the reason EVOO may be more protective than refined olive oil, though trials measuring hard cardiovascular endpoints have not confirmed a meaningful clinical benefit. amplify this pathway via cyclic-GMP signaling.

Oxidative Stress Modulation

Espécies reativas de oxigênioReactive oxygen species are unstable oxygen-containing molecules produced as a by-product of normal metabolism. (ROS) generated by NADPH oxidase and uncoupled eNOS accelerate aterogêneseAtherogenesis is the step-by-step process of a plaque forming.. Regression is accompanied by activation of the antioxidanteUm antioxidante é uma substância que elimina moléculas nocivas no corpo. A vitamina E e o betacaroteno são exemplos. transcription factor Nrf2, up-regulation of heme-oxygenase-1, and reduced lipid peroxidationLipid peroxidation is a chain reaction in which reactive oxygen species attack the double bonds in unsaturated fatty acids, breaking them down into potentially harmful oxidation products; polyunsaturated fats in seed oils are more susceptible to this process than saturated or monounsaturated fats, particularly under heat or repeated frying.. These shifts lower endothelial permeability and preserve NO bioavailability.

Endothelial Progenitor Cells and Repair

High-intensity statinsA high-intensity statin is a dose expected to cut LDL by 50 percent or more — in practice, higher doses of atorvastatin or rosuvastatin., exercício aeróbicoExercício aeróbico é uma atividade contínua que faz você respirar com mais intensidade por um tempo, como caminhar rápido, andar de bicicleta, nadar ou correr., and WFPB nutrition each mobilize endothelial progenitor cellsBone-marrow-derived precursor cells that circulate in the bloodstream and home to sites of endothelial injury, where they participate in re-endothelialization and microvascular repair; their mobilization is enhanced by statins, aerobic exercise, and whole-food plant-based nutrition. from bone marrow, facilitating re-endothelialization and improving microvascular health.

Cumulatively, these processes transform plaques from lipid-laden and rupture-prone to fibrotic and quiescent—an authentic form of arterial healing even when lumen diameter remains unchanged.

Foundational Evidence from Primate Models

Long before human imaging trials, foundational work in nonhuman primate models established the biological plausibility of regression. These studies demonstrated that after inducing atherosclerosis with cholesterol-rich diets, switching to a regression (low-fat) diet caused marked lipid depletion from arterial walls, endothelial repair, and structural stabilization of lesions. This early animal data confirmed that atherosclerosis was not an irreversible endpoint but a dynamic process responsive to profound changes in the lipid environment.

Table 1. Regression Studies in Nonhuman Primates

Comparative primate models illustrating biologic mechanisms of lipid depletion, endothelial repair, and structural regression following dietary or pharmacologic intervention.

Estudo	Species	Intervenção	Duration	Resultado
Armstrong et al, 1970¹³	Rhesus monkey	Low-cholesterol diet after atherogenic feeding	24 mo	Marked lipid depletion and endothelial repair
Vesselinovitch & Wissler, 1976¹⁴	Cynomolgus monkey	Cholesterol-withdrawal diet	18 mo	Wall lipid loss and matrix healing
Clarkson et al, 1981¹⁵	Macaco-rhesus	Regression (low-fat) diet	48 mo	Reduced intimal thickness and stabilized lesions
Hecker et al, 2022¹⁶	Cynomolgus monkey	Regression diet + LDL-lowering therapy	12 mo	Lower oxidative stress and improved endothelial NO

Pharmacologic Regression: Statins, PCSK9 Inhibitors, and Omega-3 Therapy

High-Intensity Statins

O Estudo ASTEROIDA landmark 2006 serial IVUS study in which rosuvastatin 40 mg daily for 24 months produced statistically significant reductions in both percent atheroma volume and total atheroma volume, providing the first large-scale evidence that intensive statin therapy can regress coronary plaque. demonstrated that rossuvastatinaA rosuvastatina, vendida como Crestor, é a estatinas mais potente disponível e permanece em grande parte no fígado em vez de se espalhar pelo corpo. reduzido para 40 mg ao dia volume percentual de ateromaPercent atheroma volume, or PAV, is the share of an artery segment taken up by plaque rather than open channel. (PAV) by 0.98% and volume total de ateromaTotal atheroma volume is an IVUS-derived absolute measure of the total three-dimensional volume of plaque within an imaged coronary segment, reported in cubic millimeters. Unlike PAV, TAV is not normalized to vessel size, so it captures the raw amount of disease removed or added over time. by 6.8% over 24 months.¹ The ensaio SATURNA head-to-head serial IVUS trial comparing rosuvastatin 40 mg with atorvastatin 80 mg over 24 months; both regimens produced coronary plaque regression, confirming that intensive therapy with either high-potency statin achieves similar plaque-volume reductions. confirmed these findings across two potent statins, showing that the extent of LDL-C reduction correlated directly with regression magnitude.² Beyond lipid lowering, statins exhibit pleiotropic effectsIn pharmacology, pleiotropic effects are actions of a drug that go beyond its primary intended mechanism; for incretin therapies, pleiotropic effects include anti-inflammatory activity, endothelial protection, and blood-pressure reduction that are independent of the drugs' primary glucose-lowering and weight-loss actions.: decreased Proteína C-reativaA proteína C-reativa, ou PCR, é uma substância que o fígado produz quando há inflamação em alguma parte do corpo. Uma versão sensível do teste, a PCR-hs, é usada para estimar o risco cardíaco., improved eNOS coupling, and reduced oxidative stress.³ These anti-inflammatory benefits help explain event reduction even at modest LDL levels.

PCSK9 Inhibitors

PCSK9A PCSK9 é uma proteína produzida pelo seu fígado que destrói os pontos de ancoragem que o fígado usa para retirar o colesterol do seu sangue. promotes lysosomal degradation of hepatic Receptores de LDLO receptor de LDL é uma porta de ancoragem nas células do fígado que captura partículas de LDL do sangue e as puxa para serem decompostas.. Monoclonal antibody inhibition (evolocumabeEvolocumabe é um medicamento injetável para o colesterol da família dos inibidores da PCSK9, geralmente administrado a cada duas a quatro semanas., alirocumabeAlirocumab, vendido como Praluent, é um anticorpo injetável que bloqueia a PCSK9, administrado a cada duas a quatro semanas.) enhances receptor recycling, producing LDL-C values <30 mg/dL. In GLAGOVGLAGOV added a PCSK9 inhibitor to statin therapy and measured coronary plaque with intravascular ultrasound before and after., evolocumab plus statin therapy yielded an additional 1% reduction in PAV versus statin alone.⁴ PACMAN-AMIPACMAN-AMI gave a PCSK9 inhibitor to patients immediately after a heart attack and imaged their non-culprit arteries with three different catheter techniques. e HuygensHUYGENS used optical coherence tomography — a very high-resolution imaging catheter — to see whether a PCSK9 inhibitor changed plaque structure after a heart attack. revealed thicker cápsulas fibrosasThe fibrous cap is the tough layer of tissue covering a plaque, separating its greasy core from the bloodstream. and smaller núcleos lipídicosThe lipid core is the soft, greasy center of a plaque, made of cholesterol and the debris of dead immune cells. with PCSK9 inhibition.⁵⁻⁶ Despite these histologic benefits, mean luminal area changed little, consistent with reverse remodeling rather than persistent obstruction.

Omega-3 Fatty Acids (Icosapent Ethyl)

In EVAPORATE, high-dose icosapento de etilaIcosapent ethyl is a purified, high-dose form of the omega-3 fat EPA, sold as Vascepa. reduzido placa de baixa atenuaçãoLow-attenuation plaque is the very darkest, fattiest plaque on a CT scan — soft enough that X-rays pass through it easily. by 17% versus placeboUm placebo é um tratamento falso — uma pílula de açúcar ou uma injeção de solução salina — administrado para que os pesquisadores possam determinar o que um medicamento real realmente faz. and increased fibrous tissue.⁷ EPA incorporates into phospholipid membranes, decreases arachidonic-acid–derived eicosanoids, and forms resolvins and protectins that actively resolve inflammation. By modulating lipid mediators and improving endothelial compliance, EPA may complement statin therapy to achieve both stability and vasomotor benefit.

Whole-Food, Plant-Based Lifestyle and Coronary Regression

Dean Ornish’s studies remain foundational. In The Lancet (1990) and JAMA (1998) trials, participants following a low-fat, WFPB diet combined with stress management, exercise, and tabagismoFumar danifica o revestimento dos vasos sanguíneos, aumenta a pressão arterial, faz o sangue coagular mais facilmente e acelera o crescimento de placas. cessation showed a 7.9% angiographic improvement in estenoseStenosis is narrowing — usually described as a percentage, like a 70 percent blockage. at five years without pharmacologic therapy.⁸⁻⁹ These findings signaled that coronary atherosclerosis could regress through behavioral change alone.

Mechanisms of Lifestyle-Driven Regression

• Lipid effects: Eliminating animal fat reduces hepatic LDL output; soluble fibraA fibra é a parte do alimento vegetal que seu corpo não consegue digerir. Ela é encontrada em feijões, aveia, vegetais, frutas e grãos integrais. enhances cholesterol excretion.
• Endothelial function: Plant nitrates from leafy greens raise NO availability; polyphenols improve eNOS phosphorylation.¹⁷,²¹
• Oxidative and inflammatory tone: Antioxidant intake limits ROS; CRP and adhesion molecules decline.²⁰,²²
• Microbiome modulation: Reduced production of trimethylamine N-oxide (TMAOTMAO is a compound your gut bacteria produce from nutrients found in red meat, eggs, and some fish. Higher blood levels have been linked to heart disease.) and increased short-chain fatty acids lower systemic inflammation.
• Metabolic integration: Improved sensibilidade à insulinaInsulin sensitivity is how well your cells respond to insulin. It is the opposite of insulin resistance. and reduced lipemia pós-prandialPostprandial lipemia is the surge of fat particles in your blood in the hours after eating a meal containing fat. relieve endothelial stress.

Large cohort data (Adventist Health Study-2, EPIC-OxfordUma ampla coorte prospectiva baseada no Reino Unido que recrutou uma proporção substancial de vegetarianos e veganos, fazendo parte da investigação europeia mais ampla sobre o cancro e a nutrição (EPIC); relatou um risco total de AVC mais elevado — impulsionado pelo AVC hemorrágico — entre vegetarianos em comparação com comedores de carne.) confirm lower doença cardíaca isquêmicaUma condição em que o suprimento sanguíneo reduzido para o músculo cardíaco, geralmente devido à aterosclerose das artérias coronárias, causa sintomas como angina ou infarto do miocárdio. incidence among predominantly plant-based populations. Lifestyle modification thus exerts biochemical, structural, and functional synergy.

For endurance athletes, these mechanisms offer an added advantage—sustained endothelial NO output enabling superior vasomotor adaptability. Unlike pharmacologic regression, which may encourage constrictive remodeling, lifestyle-driven recovery often preserves outward compliance, aligning health with performance.

Imaging Evidence and the Nature of Plaque Regression

Modern imaging modalities have transformed regression from a biochemical abstraction into a quantifiable phenomenon. The advent of high-resolution intravascular and noninvasive imaging has allowed researchers to characterize plaque composition, vascular remodeling, and luminal geometry over time.

Intravascular Ultrasound (IVUS)

IVUS has been the cornerstone of regression trials since the 1990s. It enables three-dimensional volumetric assessment of ateromaAtheroma is another word for the fatty deposit inside an artery wall — essentially a synonym for plaque, used more often in research writing. burden and vessel wall area. Unlike angiography, which reflects only the lumen, IVUS visualizes the entire arterial wall, revealing compensatory remodeling, lipid pools, and calcificaçãoCalcification is when calcium gets deposited into a plaque, turning part of it hard and bony.. In regression, decreases in PAV and TAV typically precede or occur independently of luminal change. Virtual histology (VH-IVUS) further distinguishes plaque components, demonstrating that intensive lipid lowering increases fibrous content and reduces núcleo necróticoThe necrotic core is the dead, mushy center of an advanced plaque, built from immune cells that ate trapped cholesterol and then died in place. volume.

Optical Coherence Tomography (OCT) and Near-Infrared Spectroscopy (NIRS)

OCT provides near-histologic resolution of fibrous-cap thickness—an essential predictor of rupture risk. Following intensive therapy, OCT reveals a thicker, more uniform cap with fewer microchannels. NIRS and NIRS-IVUS hybrid catheters can quantify lipid-core burden index (LCBI)A near-infrared spectroscopy (NIRS) measurement that quantifies the lipid content within a coronary plaque segment; reductions in LCBI under intensive therapy indicate that the plaque's vulnerable, lipid-rich core is shrinking., showing significant decreases under PCSK9 or omega-3 therapy. Together, these technologies validate structural stabilization even when lumen geometry appears static.

Coronary Computed Tomography Angiography (CCTA)

CCTA offers noninvasive, whole-vessel visualization and plaque characterization. In trials such as EVAPORATE, CCTA demonstrated marked regression of low-attenuation, placa rica em lipídiosAn atherosclerotic lesion whose core is dominated by cholesterol esters and inflammatory lipids rather than calcium or fibrous tissue; the article notes that such plaques are highly responsive to intensive treatment and that the dramatic 65-percentage-point regression at the diagonal branch origin is consistent with reversal of a lipid-rich lesion. following high-dose EPA.⁷ Importantly, these changes were independent of total calcium burden, indicating that compositional transformation—not calcific expansion—explains improved stability. Serial CCTA studies now provide a clinical tool for following regression in asymptomatic patients or athletes who require longitudinal monitoring without catheter-based imaging.

Magnetic Resonance Imaging (MRI)

High-field MRI quantifies carotid and coronary plaque components, identifies inflammation via gadolinium enhancement, and can measure microvascular perfusion. Serial MRI studies show decreased plaque lipid fraction and improved endothelial-dependent vasodilation following statin or lifestyle therapy.¹²

Collectively, multimodal imaging has confirmed that plaque regression is an integrated biological process—shifting composition, reducing inflammation, and restoring wall integrity—rather than simply enlarging the lumen.

Table 2. Major Human Regression Trials

Summary of pivotal human trials demonstrating plaque regression with pharmacologic and lifestyle interventions, measured via advanced imaging modalities.

Estudo	Intervenção	Imaging	Plaque Effect	Lumen Effect
ASTEROID¹	Rosuvastatin 40 mg	IVUS	↓PAV 0.98%, ↓TAV 6.8%	Neutral
SATURN²	Rosuvastatin vs AtorvastatinaAtorvastatin, sold as Lipitor, is one of the two strongest statins and among the most prescribed medicines in the world.	IVUS	Regression in both groups	Variável
GLAGOV⁴	Evolocumab + Statin	IVUS	Greater regression	Neutral
EVAPORATE⁷	Icosapent Ethyl + Statin	CCTA	↓Lipid-rich plaque	Neutral
ORNISH⁸⁻⁹	Whole-Food, Plant-Based Lifestyle	QCA	Mild angiographic improvement	Functional gain

The Lumen Paradox and Reverse Remodeling

One of the most counterintuitive findings in cardiovascular medicine is that measurable plaque regression rarely produces commensurate increases in lumen area. This lumen paradox originates from the mechanical behavior of arteries under chronic stress.

In the 1987 Glagov study, human autopsies demonstrated aumento compensatórioCompensatory enlargement, described by Glagov, is the outward expansion of an artery's wall as plaque accumulates inside it, allowing the channel where blood flows to remain relatively open despite substantial hidden disease; on modern CT imaging, this positive remodeling is considered a high-risk plaque feature associated with lipid-rich, potentially vulnerable plaque rather than evidence of hea… of the membrana elástica externa (MEE)The external elastic membrane is the boundary between an artery's muscular wall and surrounding connective tissue; in intravascular imaging, the area enclosed by the EEM is used to quantify total vessel size including both the open channel and the plaque within the wall. during plaque growth—a mechanism preserving lumen size until approximately 40% of the cross-sectional area is occupied by plaque.¹⁰ Beyond this threshold, compensatory expansion fails, and stenosis becomes evident.

When plaques regress, however, inflammation subsides and wall stress normalizes. The EEM may contract, reversing prior dilation. This reverse remodeling results in smaller or unchanged luminal areas even though plaque burden decreases and arterial wall composition improves.¹¹ Far from pathological, this constrictive adjustment restores physiologic tension across the media and adventitiaA adventícia é a camada mais externa e resistente de uma artéria, composta principalmente de tecido conjuntivo, nervos e pequenos vasos que alimentam a parede..

Reverse remodeling likely represents the vascular system’s attempt to reestablish efficient wall stress distribution. Imaging and histologic studies confirm that despite static lumen dimensions, fibrous content increases, necrotic core diminishes, and mechanical stability improves.¹²

Implications for Endurance Athletes

For endurance athletes, the paradox raises practical questions. Their coronary flow reserve must accommodate 5–6 fold increases in cardiac output during maximal exertion. Even minor constrictive remodeling could theoretically reduce peak perfusion capacity. Yet, this risk may be mitigated by enhanced endothelial function and óxido nítricoNitric oxide is a gas your blood vessel lining makes to tell the vessel to relax and widen.–mediated vasodilation in athletes, which can expand lumen radius dynamically during exercise. Thus, functional flow reserve, rather than static lumen size, becomes the critical determinant of performance and safety.

Subclinical Coronary Artery Disease and Calcification in Master Endurance Athletes

Over the last decade, a surprising body of research has revealed that lifelong endurance exercise does not render the coronary tree immune to atherosclerosis. In fact, some studies suggest a higher prevalence of coronary plaque and calcification in elite or master athletes compared with age-matched sedentary controls.

The Merghani et al. Study (2017, Circulation)

Merghani and colleagues examined 152 male and female master endurance athletes (mean age 54) and compared them with 92 healthy controls matched for age and fatores de riscoUm fator de risco é algo que aumenta a sua chance de desenvolver uma doença — partículas de colesterol alto, pressão alta, tabagismo, diabetes, histórico familiar..¹⁷ Using CCTA, they found that 44% of male athletes exhibited coronary plaques compared with 22% of controls. Eleven percent of athletes had escores de cálcioUm escore de cálcio (escore de cálcio das artérias coronárias) é um número derivado de uma tomografia computadorizada que quantifica a quantidade total de placa calcificada nas artérias coronárias; um escore zero indica ausência de placa calcificada detectável, enquanto escores mais altos refletem maior carga de placa e risco cardiovascular elevado. greater than 300 Agatston unitsAs unidades Agatston são as unidades de pontuação padronizadas usadas para quantificar o cálcio da artéria coronária em uma tomografia computadorizada, calculadas a partir da densidade e da área das lesões calcificadas; uma pontuação de zero indica ausência de placa calcificada detectável, enquanto pontuações de 300 ou mais — encontradas exclusivamente no grupo de atletas no estudo UK Masters — refletem calcificação pesada., and 7.5% had luminal stenoses exceeding 50%. Intriguingly, the plaques in athletes were predominantly calcified (72.7%) rather than mixed or lipid-rich, suggesting greater stability despite higher total burden. Furthermore, 14% of male athletes displayed silent myocardial fibrosis on cardiac MRICardiac MRI uses magnetic fields rather than X-rays to image the heart in fine detail, with no radiation.—evidence of prior subclinical ischemic injury.

Confirmatory and Contrasting Studies

These findings were expanded by Aengevaeren et al. (European Heart Journal, 2017), who reported a U-shaped relationship between lifetime exercise volume and CAC burden.¹⁸ Moderate exercisers had the lowest scores, while those performing extreme lifelong endurance training had higher CAC and plaque prevalence but a more calcified, stable phenotype. Baggish and Levine (2017) interpreted these data as an adaptation—exercise may accelerate calcification of existing soft plaquesNon-calcified, lipid-rich atherosclerotic plaque that does not appear bright on a standard calcium score scan but is detectable by CT angiography; it is considered higher risk for rupture than fully calcified plaque., converting them into stable, quiescent structures less likely to rupture.¹⁹

Mechanistic Hypotheses

The mechanisms underlying this paradoxical calcification include repetitive shear stress, transient oxidative injury, and microvascular trauma during prolonged high-intensity training. These stimuli can induce vascular smooth-muscle cell osteogenic transformation, promoting microcalcificaçãoMicroscopic calcium deposits within atherosclerotic plaque that fall below the resolution threshold of conventional CT; unlike dense macrocalcification, microcalcifications can generate mechanical stress within the fibrous cap and increase plaque rupture susceptibility. that later consolidates into dense calcium sheets.

Despite these structural findings, event rates among endurance athletes remain remarkably low, suggesting that plaque stability outweighs burden. Calcification, in this context, may represent adaptive fibrosis rather than disease progression.

Clinical Implications for Screening

These insights reshape preventive cardiology in athletes. Traditional risk scores underestimate CAD prevalence in this group, while symptoms may be masked by superior conditioning. Selective imaging—particularly CAC scoring or CCTA—is appropriate for athletes over 45 with histórico familiarFamily history means whether your close relatives developed heart disease, and how young they were when it happened., dislipidemiaDyslipidemia is the medical word for an unhealthy pattern of fats in the blood. It can mean high LDL, high triglycerides, low HDL, or some combination., or unexplained performance decline. Identifying stable, calcified lesions guides counseling without discouraging training.

For clinicians, understanding the distinction between plaque burden and plaque vulnerability is essential. A highly calcified lesion may signal a healed or stabilized artériaUma artéria é um vaso sanguíneo que transporta o sangue do coração para o resto do corpo., whereas non-calcified, lipid-rich plaques remain the real threat—even in the apparently “fittest” hearts.

Silent Ischemia and Pain Processing in Endurance Athletes

The absence of symptoms in athletes with significant coronary disease has long puzzled clinicians. This “isquemia silenciosaSilent ischemia is when the heart muscle is starved of oxygen but the person feels nothing at all.” phenomenon is now understood as a consequence of neurobiologic adaptation to chronic exertion and repeated sympathetic activation.

Neurophysiologic Basis

Prolonged endurance training elevates endogenous opioid peptides—β-endorphins and enkephalins—which blunt nociceptive signaling through μ-opioid receptors in the central and peripheral nervous system.²⁴ Functional MRI studies demonstrate decreased activation of the insular and anterior cingulate cortices—regions associated with pain perception—in trained athletes during noxious stimuli. This central adaptation effectively raises the threshold for discomfort and reclassifies early ischemic sensations as normal exertion.

Clinical Evidence

Several cohorts of master athletes have shown electrocardiographic or perfusion evidence of myocardial isquemiaIsquemia é quando um tecido não está recebendo sangue e oxigênio suficientes para o que lhe está sendo exigido. in the absence of chest pain. Exercise thallium imaging studies from the 1990s first identified this pattern; more recent PET and MRI data confirm ischemia without anginaAngina is chest discomfort that happens when the heart muscle isn't getting enough oxygen. People describe it as pressure, tightness, squeezing, or burning, and it can spread to the arm, neck, or jaw. during maximal workloads. Importantly, some of these athletes exhibit realce tardio por gadolínioLate gadolinium enhancement (LGE) is a cardiac MRI technique in which a contrast agent accumulates in areas of scarred or fibrotic myocardium and appears bright on delayed imaging, indicating previous microscopic or clinical cardiac injury; 12–14% of masters athletes in the studies described showed this pattern, sometimes without any prior diagnosed heart attack. consistent with silent myocardial fibrosis—“healed” infarcts unrecognized during life.¹⁷

Implications for Clinical Assessment

Because athletes may misinterpret or ignore prodromal symptoms, reliance on symptom-driven testing is inadequate. Cardiologists should consider baseline CAC or CCTA screening in athletes over 45 years old, particularly those with familial dyslipidemia or long training histories. Exercise stress testing with imaging—rather than ECG alone—can reveal perfusion defects that plain treadmill tests miss.²³ Recognition of silent ischemia is crucial to prevent sudden eventos cardíacosClinically significant heart-related occurrences—including myocardial infarction, unstable angina, and cardiac death—used as outcome endpoints in cardiovascular trials. during competition.

Hemodynamic Principles: Why Millimeters Matter

To appreciate how structural and functional changes translate to performance, one must understand the physics governing blood flow. Coronary blood flow follows Poiseuille’s law, which states:

$$Q = \frac{\pi \cdot \Delta P \cdot r^4}{8 \cdot \mu \cdot L}$$

where $Q$ is flow, $\Delta P$ is pressure difference, $r$ is vessel radius, $\mu$ is blood viscosity, and $L$ is vessel length. Flow thus increases with the fourth power of radius.

Physiologic Consequences

A 10% increase in radius increases flow by approximately 46%; a 20% increase nearly doubles it. Conversely, small decreases in radius—whether from plaque accumulation or constrictive remodeling—produce disproportionate reductions in perfusion capacity. For endurance athletes whose cardiac output may reach 30 L/min, these geometric nuances determine the ceiling of aerobic performance.

Dynamic Vasomotion

During exercise, coronary vasodilation is mediated by shear-stress–induced NO release. Healthy endotélioO endotélio é o revestimento ultrafino e escorregadio no interior de cada vaso sanguíneo. Ele tem a espessura de apenas uma célula. expands epicardial vessels and dilates arterioles to match myocardial oxygen demand. When disfunção endotelialEndothelial dysfunction is when that thin lining stops doing its job well. Vessels don't widen properly, and the barrier gets leakier. coexists with plaque, this dilation reserve is blunted. Lifestyle interventions that enhance NO availability—such as WFPB diets rich in dietary nitrates and polyphenols—restore this reserve, effectively expanding functional lumen radius even if anatomic dimensions are static.

Integration with Regression

Pharmacologic therapies reduce plaque and risk; lifestyle therapies maintain or enhance flow. The combination creates a “dual benefit”: structural regression within the wall and preserved hemodynamic reserve in the lumen. This synergy underpins the thesis that optimal care of the endurance athlete requires both medical and nutritional precision.

Clinical Implications and Author Perspective

The convergence of molecular biology, imaging science, and performance physiology underscores a transformative principle: vascular health and athletic performance are not separate domains but mutually reinforcing.

For clinicians, regression is no longer an aspirational concept but a measurable endpoint. Percent atheroma volume, plaque composition, and cap thickness have replaced crude angiographic narrowing as markers of success. Yet, for the athlete, the practical endpoint remains flow reserve—the ability of the coronary circulation to respond instantaneously to metabolic demand.

Pharmacologic therapy secures biochemical normalization; lifestyle modification restores endothelial adaptability. The challenge is to personalize interventions such that structural regression does not come at the expense of vasomotor responsiveness.

It is within this framework that Dr. Peter Megdal’s personal experience becomes instructive.

Author Reflection: The N + 1 Story — Healing, Adaptation, and Performance

Dr. Peter Megdal, a lifelong endurance athlete and scientist, exemplifies the dual pursuit of vascular healing and human performance. In his early fifties, despite holding several age-group world records in ultra-endurance events, he was unexpectedly found to have subclinical coronary atherosclerosis during imaging performed for research. The discovery was paradoxical: how could someone with exceptional aerobic capacity harbor measurable plaque?

Rather than view this as defeat, Dr. Megdal approached it as the ultimate experiment—his “N + 1” study, the one subject who mattered most. Drawing on decades of biochemical expertise, he implemented a rigorous combination of intensive lipid lowering, whole-food plant-based nutrition, and structured endurance training designed around recovery and endothelial optimization.

Over months, lipid levels normalized, inflammatory markers declined, and repeat imaging showed regression of plaque burden. Endothelial function, assessed by flow-mediated dilation, improved dramatically. Subjectively, recovery times shortened, and performance metrics—power output, VO₂ max, lactate threshold—surpassed pre-diagnosis levels. Within two years, he returned to elite competition and established new age-group world records, a living demonstration that arterial healing and peak human function can coexist.

Dr. Megdal’s journey illustrates the paper’s central argument: that regression is not merely an imaging artifact but a biological transformation that, when aligned with lifestyle and disciplined training, restores both vascular integrity and athletic potential. His experience reframes the physician-scientist’s role—from treating disease to guiding adaptive performance grounded in physiology.

Future Directions

1. Beyond LDL: Molecular and Functional Targets

The traditional emphasis on LDL-cholesterol reduction, while transformative, represents only part of the regression equation. Future therapies will increasingly target residual inflammatory and oxidative pathways. Agents modulating interleukin-1β (e.g., canakinumabeCanakinumab is a monoclonal antibody that targets interleukin-1β (IL-1β), a key inflammatory signaling protein; it was the active drug in the CANTOS trial, where it reduced cardiovascular events without affecting LDL cholesterol.) or lipoproteína(a)Lipoproteína(a), escrita como Lp(a) e pronunciada como "L-P-minúsculo-a", é uma partícula semelhante ao LDL com uma proteína extra pegajosa anexada. hold promise for individuals with low LDL yet persistent plaque activity. For athletes, whose oxidative flux is naturally elevated, therapies that temper reactive oxygen species without blunting mitochondrial adaptation may optimize both vascular and muscular recovery.

Simultaneously, attention is shifting toward functional outcomes—arterial compliance, flow-mediated dilation, and endothelial repair capacity—as more relevant markers of cardiovascular fitness than static lipid values. Integration of these physiologic metrics into athletic screening may redefine how cardiometabolic performance is measured.

2. Advanced Imaging and Computational Hemodynamics

Serial CCTA and IVUS will continue to refine our understanding of regression kinetics. Next-generation photon-counting CT and ultra-high-resolution MRI promise to detect microcalcification, cap thickness, and neovascularizationNeovascularization is the growth of new blood vessels. Inside a plaque, they sprout from the vessels feeding the artery's own wall. with unprecedented clarity. When paired with computational fluid dynamics, these images can model shear stress distribution, predicting which plaques will regress or stabilize under various interventions.

For athletes, such modeling could reveal how training intensity, variabilidade da frequência cardíacaHeart rate variability (HRV) is the natural beat-to-beat variation in the time between heartbeats, and is used as a non-invasive measure of autonomic nervous system balance — higher variability generally reflecting greater parasympathetic (rest-and-digest) activity. It is listed in the article as one of the outcomes measured in meditation trials., and coronary flow patterns interact with plaque biology—a fusion of engineering and medicine that may personalize training prescriptions to minimize vascular stress.

3. Lifestyle–Pharmacologic Synergy

Emerging evidence supports a hybrid model: pharmacologic LDL-C suppression combined with whole-food, plant-based nutrition to sustain endothelial tone and systemic saúde metabólicaMetabolic health describes how well your body handles blood sugar, blood pressure, fats, and body fat storage.. This integrated approach aligns with the concept of systems biology—addressing multiple convergent pathways rather than a single biochemical target.

Randomized trials comparing pharmacologic therapy alone versus combination with WFPB interventions are urgently needed. Endpoints should extend beyond plaque regression to include arterial elasticity, flow reserve, and athletic performance metrics. Such studies could redefine cardiovascular prevention as a continuum between disease management and physiologic optimization.

4. Exercise Physiology and Adaptive Remodeling

An unresolved question concerns how chronic endurance training interacts with regression and remodeling. Is the increased calcification seen in lifelong athletes a benign stabilization process or an adaptive trade-off? Understanding the cellular signals that drive osteogenic transformation in vascular smooth muscle could reveal ways to preserve arterial flexibility without compromising stability.

Future research should distinguish between beneficial physiologic remodeling and maladaptive calcification, possibly through longitudinal cohorts combining high-resolution imaging with molecular biomarcadoresUm biomarcador é algo mensurável no corpo que informa sobre saúde ou doença — um valor laboratorial, o resultado de um exame de imagem, uma leitura da pressão arterial. of bone–vascular crosstalk (e.g., osteoprotegerin, BMP-2).

5. Precision Prevention in Athletic Cardiology

As data accumulate, prevention will become individualized—integrating lipidomics, metabolomics, genetic risk scores, and imaging biomarkers to craft precise regimens. Machine-learning models may soon predict who among master athletes is most likely to develop subclinical CAD despite fitness, and who will benefit most from aggressive lipid lowering versus lifestyle modification alone.

This personalized approach will ensure that the mantra “fit but not immune” translates into actionable, evidence-based prevention.

Conclusão

Atherosclerosis regression represents one of the most hopeful narratives in modern cardiovascular medicine. It is not merely the reversãoO estudo REVERSAL comparou a terapia com estatinas moderada e intensiva, utilizando ultrassom intravascular para medir o que aconteceu com a placa coronariana. of a pathological process but the reawakening of the vessel’s innate capacity for repair. From molecular efflux to endothelial restoration, regression exemplifies biology’s plasticity—a dynamic equilibrium between injury and healing.

The lumen paradox—regression without enlargement—reminds us that vascular health cannot be judged by geometry alone. Stability, composition, and functional responsiveness are equally vital. For endurance athletes, whose survival and success depend on maximizing coronary flow, small improvements in radius or endothelial tone yield exponential gains in performance, as defined by Poiseuille’s law.

Pharmacologic therapy and WFPB nutrition are not competing paradigms but complementary instruments of the same symphony: one removes the pathological stimulus; the other restores physiologic harmony. Together they promote a vessel that is not only structurally sound but dynamically alive.

Dr. Peter Megdal’s “N + 1 Story” embodies this synthesis. His journey from the discovery of aterosclerose subclínicaAterosclerose subclínica significa que há presença de placa, mas ela ainda não causou nenhum sintoma ou evento. to documented regression and renewed world-record performance symbolizes the translation of scientific knowledge into human transformation. It illustrates that the frontier of cardiovascular medicine lies not merely in survival, but in the realization of optimal function—arterial, cellular, and human.

Acknowledgment

The author reports no conflicts of interest.

Referências

1. Nissen SE, Nicholls SJ, Sipahi I, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA. 2006;295(13):1556-1565. doi:10.1001/jama.295.13.jpc60002
2. Nicholls SJ, Ballantyne CM, Barter PJ, et al. Effect of two intensive statin regimens on progression of coronary disease. N Engl J Med. 2011;365(22):2078-2087. doi:10.1056/NEJMoa1110874
3. Rivera FB, Cha SW, Varona MC, et al. Atherosclerotic coronary plaque regression from lipid-lowering therapies: A meta-analysis and meta-regression. Am J Prev Cardiol. 2024;18:100645. Published 2024 Mar 11. doi:10.1016/j.ajpc.2024.100645
4. Nicholls SJ, Puri R, Anderson T, et al. Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial. JAMA. 2016;316(22):2373-2384. doi:10.1001/jama.2016.16951
5. Räber L, Ueki Y, Otsuka T, et al. Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial. JAMA. 2022;327(18):1771-1781. doi:10.1001/jama.2022.5218
6. Oyama K, Furtado RHM, Fagundes A Jr, et al. Effect of Evolocumab on Complex Coronary Disease Requiring Revascularization. J Am Coll Cardiol. 2021;77(3):259-267. doi:10.1016/j.jacc.2020.11.011
7. Budoff MJ, Bhatt DL, Kinninger A, et al. Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial. Eur Heart J. 2020;41(40):3925-3932. doi:10.1093/eurheartj/ehaa652
8. Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet. 1990;336(8708):129-133. doi:10.1016/0140-6736(90)91656-u
9. Ornish D, Scherwitz LW, Billings JH, et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA. 1998;280(23):2001-2007. doi:10.1001/jama.280.23.2001
10. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316(22):1371-1375. doi:10.1056/NEJM198705283162204
11. Tsujita K, Sugiyama S, Sumida H, et al. Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSound (PRECISE-IVUS Trial): Study protocol for a randomized controlled trial. J Cardiol. 2015;66(4):353-358. doi:10.1016/j.jjcc.2014.12.011
12. Yuan C, Kerwin WS, Yarnykh VL, et al. MRI of atherosclerosis in clinical trials. NMR Biomed. 2006;19(6):636-654. doi:10.1002/nbm.1065
13. Armstrong ML, Warner ED, Connor WE. Regression of coronary atheromatosis in rhesus monkeys. Circ Res. 1970;27(1):59-67. doi:10.1161/01.res.27.1.59
14. Weingand KW. Atherosclerosis research in cynomolgus monkeys (Macaca fascicularis). Exp Mol Pathol. 1989;50(1):1-15. doi:10.1016/0014-4800(89)90052-x
15. Yamada T, Yoshikuni Y, Taira M, et al. Diet-induced atherosclerosis in cynomolgus monkey aorta and regression by the sixth-month observation. Angiology. 1992;43(12):1008-1019. doi:10.1177/000331979204301207
16. Hecker M, Moser M, Schmoldt H, et al. Regression of atherosclerosis with LDL lowering and oxidative stress reduction in primates. Sci Rep. 2022;12(1):4589.
17. Merghani A, Maestrini V, Rosmini S, et al. Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile. Circulation. 2017;136(2):126-137. doi:10.1161/CIRCULATIONAHA.116.026964
18. Aengevaeren VL, Mosterd A, Braber TL, et al. Relationship Between Lifelong Exercise Volume and Coronary Atherosclerosis in Athletes. Circulation. 2017;136(2):138-148. doi:10.1161/CIRCULATIONAHA.117.027834
19. Baggish AL, Levine BD. Coronary Artery Calcification Among Endurance Athletes: “Hearts of Stone”. Circulation. 2017;136(2):149-151. doi:10.1161/CIRCULATIONAHA.117.028750
20. Esposito K, Marfella R, Ciotola M, et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004;292(12):1440-1446. doi:10.1001/jama.292.12.1440
21. Mathur R, Ahmid Z, Ashor AW, Shannon O, Stephan BCM, Siervo M. Effects of dietary-based weight loss interventions on biomarkers of endothelial function: a systematic review and meta-analysis. Eur J Clin Nutr. 2023;77(10):927-940. doi:10.1038/s41430-023-01307-6
22. Dod HS, Bhardwaj R, Sajja V, et al. Effect of intensive lifestyle changes on endothelial function and on inflammatory markers of atherosclerosis. Am J Cardiol. 2010;105(3):362-367. doi:10.1016/j.amjcard.2009.09.038
23. Sharma S, Merghani A, Mont L. Exercise and the heart: the good, the bad, and the ugly. Eur Heart J. 2015;36(23):1445-1453. doi:10.1093/eurheartj/ehv090
24. Thornton C, Baird A, Sheffield D. Athletes and Experimental Pain: A Systematic Review and Meta-Analysis. J Pain. 2024;25(6):104450. doi:10.1016/j.jpain.2023.12.007